|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent Intra-Cellular Therapies insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why Intra-Cellular Therapies insider buys are important for investors to follow.
Date | Insider | Price | Amount |
9-14-2020 Insider Buy |
Christopher D. Alafi Director |
$29.60
CAGR »
|
$1,465,200.00 49,500 shares |
9-11-2020 Insider Buy |
Christopher D. Alafi Director |
$28.08
CAGR »
|
$589,680.00 21,000 shares |
9-10-2019 Insider Buy |
Christopher D. Alafi Director and >10% Owner |
$10.26
CAGR »
|
$4,974,677.56 485,000 shares |
8-30-2019 Insider Buy |
Christopher D. Alafi Director |
$8.52
CAGR »
|
$1,065,212.50 125,000 shares |
11-22-2017 Insider Buy |
Christopher D. Alafi Director |
$15.55
CAGR »
|
$155,500.00 10,000 shares |
5-14-2019 Insider Buy |
Christopher D. Alafi Director |
$12.56
CAGR »
|
$1,256,350.00 100,000 shares |
11-22-2017 Insider Buy |
Christopher D. Alafi Director and >10% Owner |
$15.55
CAGR »
|
$155,500.00 10,000 shares |
10-2-2017 Insider Buy |
Moshe Alafi >10% Owner |
$15.50
CAGR »
|
$4,000,007.50 258,065 shares |
10-2-2017 Insider Buy |
ALAFI CAPITAL CO LLC >10% Owner |
$15.50
CAGR »
|
$4,000,007.50 258,065 shares |
10-2-2017 Insider Buy |
Christopher D. Alafi Director and >10% Owner |
$15.50
CAGR »
|
$4,000,007.50 258,065 shares |
12-7-2016 Insider Buy |
ALAFI CAPITAL CO LLC >10% Owner |
$16.27
CAGR »
|
$1,057,483.27 65,000 shares |
12-7-2016 Insider Buy |
Christopher D. Alafi Director and >10% Owner |
$16.27
CAGR »
|
$1,057,483.27 65,000 shares |
12-7-2016 Insider Buy |
Moshe Alafi >10% Owner |
$16.27
CAGR »
|
$1,057,483.27 65,000 shares |
11-14-2016 Insider Buy |
Christopher D. Alafi Director and >10% Owner |
$14.50
CAGR »
|
$492,969.40 34,000 shares |
11-14-2016 Insider Buy |
ALAFI CAPITAL CO LLC >10% Owner |
$14.50
CAGR »
|
$492,969.40 34,000 shares |
11-14-2016 Insider Buy |
Christopher D. Alafi Director and >10% Owner |
$14.50
CAGR »
|
$492,969.40 34,000 shares |
11-14-2016 Insider Buy |
ALAFI CAPITAL CO LLC >10% Owner |
$14.50
CAGR »
|
$492,969.40 34,000 shares |
11-14-2016 Insider Buy |
Moshe Alafi >10% Owner |
$14.50
CAGR »
|
$492,969.40 34,000 shares |
2-5-2014 Insider Buy |
Rory B. Riggs Director |
$17.50
CAGR »
|
$499,992.50 28,571 shares |
2-29-2016 Insider Buy |
Christopher D. Alafi Director and >10% Owner |
$29.70
CAGR »
|
$2,970,300.00 100,000 shares |
3-11-2015 Insider Buy |
Christopher D. Alafi Director and >10% Owner |
$24.00
CAGR »
|
$15,000,000.00 625,000 shares |
12-1-2014 Insider Buy |
Christopher D. Alafi Director and >10% Owner |
$14.75
CAGR »
|
$20,974.50 1,422 shares |
12-1-2014 Insider Buy |
ALAFI CAPITAL CO LLC >10% Owner |
$14.75
CAGR »
|
$20,974.50 1,422 shares |
12-1-2014 Insider Buy |
Moshe Alafi >10% Owner |
$14.75
CAGR »
|
$20,974.50 1,422 shares |
11-28-2014 Insider Buy |
ALAFI CAPITAL CO LLC >10% Owner |
$14.75
CAGR »
|
$516,250.00 35,000 shares |
11-28-2014 Insider Buy |
Christopher D. Alafi Director and >10% Owner |
$14.75
CAGR »
|
$516,250.00 35,000 shares |
11-28-2014 Insider Buy |
Moshe Alafi >10% Owner |
$14.75
CAGR »
|
$516,250.00 35,000 shares |
11-19-2014 Insider Buy |
ALAFI CAPITAL CO LLC >10% Owner |
$14.25
CAGR »
|
$14,734.50 1,034 shares |
11-19-2014 Insider Buy |
Moshe Alafi >10% Owner |
$14.25
CAGR »
|
$14,734.50 1,034 shares |
11-19-2014 Insider Buy |
Christopher D. Alafi Director and >10% Owner |
$14.25
CAGR »
|
$14,734.50 1,034 shares |
11-18-2014 Insider Buy |
ALAFI CAPITAL CO LLC >10% Owner |
$14.26
CAGR »
|
$52,250.44 3,664 shares |
11-18-2014 Insider Buy |
Moshe Alafi >10% Owner |
$14.26
CAGR »
|
$52,250.44 3,664 shares |
11-18-2014 Insider Buy |
Christopher D. Alafi Director and >10% Owner |
$14.26
CAGR »
|
$52,250.44 3,664 shares |
11-13-2014 Insider Buy |
ALAFI CAPITAL CO LLC >10% Owner |
$15.34
CAGR »
|
$187,164.00 12,200 shares |
11-13-2014 Insider Buy |
Moshe Alafi >10% Owner |
$15.34
CAGR »
|
$187,164.00 12,200 shares |
11-13-2014 Insider Buy |
Christopher D. Alafi Director and >10% Owner |
$15.34
CAGR »
|
$187,164.00 12,200 shares |
Also See: Institutional Holders of ITCI
Also See: SEC filings
Below we present the annualized performance delivered by Intra-Cellular Therapies stock since 9-14-2020 (the date of the most recent
insider purchase). The performance of the investment from the time Intra-Cellular Therapies insider buying occurred is the ultimate
test of whether insiders were right about ITCI being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
09/15/2020 |
|
End date: |
04/26/2024 |
|
Start price/share: |
$30.35 |
|
End price/share: |
$73.26 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
141.38% |
|
Average Annual Total Return: |
27.62% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$24,141.18 |
|
Years: |
3.61 |
|
Intra-Cellular Therapies Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent Intra-Cellular Therapies insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding ITCI
|
|